Suboxone is the first opioid medication approved for the treatment of opioid dependence in an office-based setting. The primary active ingredient in Suboxone is Buprenorphine. Buprenorphine was first developed the late 60s early 70s as a painkiller but was found to be very effective in addiction treatment. It has been available as Suboxone in the United States since October 2002. To date, more than 400,000 opioid-dependent patients worldwide have been treated with Buprenorphine.
Through this treatment, people who are dependent on opiate based drugs receive comprehensive multidisciplinary outpatient treatment in order to offer the support they need to stabilize and improve their health, relationships, finances and overall quality of life.
This medicine has saved my life and changed my life drastically. I never thought I would be able to get off heroin. I have a awesome life now and I think if you really want to get better then Suboxone is what you need ---Riggs
This drug was approved for addiction treatment in 2002 in the USA and 2006 in Europe. Canada approved the medication in 2007. The first treatment centre using suboxone was at Columbia University in 2003.
Images taken from the National Alliance of Advocates for the Buprenorphine Treatment
Suboxone is very effective treatment for opioid dependence. A number of clinical trials have established that suboxone is effective for:
Suboxone Maintenance Therapy, together with counseling, can help you remain in treatment. By having your withdrawal symptoms and cravings better controlled, your overall treatment can focus on resolving issues and gaining skills to avoid triggers—situations or stimuli that may cause you to Relapse. You can also work with your physician to address issues that may have been contributing to your use of opioids, such as depression, anxiety, or other psychiatric conditions.
The Suboxone ® Opioid Substitution Program (SOSP) is an opioid pharmacotherapy program operating in the greater Toronto area. The SOSP permits our physicians to prescribe sublingual buprenorphine (suboxone) to maintain/treat opioid drug dependence, in certain circumstances.
Suboxone treatment is initiated and continued by our physicians in private individual sessions. Our team has special expertise in helping to transition patients with opioid dependence to Suboxone in the privacy and convenience of our conveniently located offices.
The Suboxone Program team consists of physicians and other clinicians, all of whom have expertise in dealing with opioid dependence and the transition to Suboxone. The team provides support for patients throughout all phases of treatment. The Suboxone Program uses the latest, well-tested treatment modalities.
A specially trained physician will assess each patient’s needs and devise an individualized treatment plan that includes initial in person dosing and a follow up plan.
Suboxone offers a more comfortable recovery from pain killer addiction. Over time, the frequency of suboxone prescriptions can be lessened, depending on each individual’s needs. Suboxone is a safer alternative to heroin or other opiate use, with reduced health risks and a lower risk profile than other treatments.
Some people report side effects. Most common are constipation (typical of all opiates), dizziness or drowsiness. Withdrawal symptoms like headache, abdominal cramps, nausea, insomnia or diarrhea may be part of the induction phase but usually resolve once the patient is stabilized.